M+W has been contracted to build a £55m manufacturing site that will support cell and gene therapy developers by the UK Government project, Cell Therapy Catapult.
UK-based processing tech provider ADC Biotechnology will build a $10m plant for the GMP manufacture of antibody-drug conjugates (ADCs).
Probiodrug has selected German CMO Rentschler to develop its Alzheimer’s monoclonal antibody candidate.
Chemical synthesis of peptides and proteins can be done at a tenth of the cost of bioproduction says French chemistry specialist Provepep.
Lonza has been contracted to develop a production process for a hepatitis C drug being trialled by gene silencing firm Benitec Biopharma.